A Safety Run-In and Phase II Study Evaluating the Efficacy, Safety, and Impact on The Tumor Microenvironment of the Combination of Tocilizumab, Atezolizumab, and Fractionated Stereotactic Radiotherapy in Recurrent Glioblastoma

Project: Research project

Project Details

StatusFinished
Effective start/end date1/1/211/1/25

Funding

  • National Cancer Institute (NCI)